|
FAM21A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49260000026352E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.60659999999258E-05 |
| Normal-vs-Stage2 |
2.05099999999181E-05 |
| Normal-vs-Stage3 |
2.33269999982966E-07 |
| Normal-vs-Stage4 |
1.258750E-03 |
| Stage1-vs-Stage2 |
1.392560E-01 |
| Stage1-vs-Stage3 |
1.069850E-01 |
| Stage1-vs-Stage4 |
9.900000E-01 |
| Stage2-vs-Stage3 |
7.643000E-01 |
| Stage2-vs-Stage4 |
2.405800E-01 |
| Stage3-vs-Stage4 |
2.586600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.90650000417992E-08 |
| Normal-vs-AfricanAmerican |
2.381200E-01 |
| Normal-vs-Asian |
9.358100E-02 |
| Caucasian-vs-AfricanAmerican |
1.877710E-02 |
| Caucasian-vs-Asian |
1.150200E-02 |
| AfricanAmerican-vs-Asian |
7.698600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24800000000924E-07 |
| Normal-vs-Female |
1.69019999995967E-06 |
| Male-vs-Female |
1.148630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.765800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.91349999956181E-07 |
| Normal-vs-Age(61-80Yrs) |
2.06489999998727E-06 |
| Normal-vs-Age(81-100Yrs) |
3.375900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.002100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.676500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.085990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.526600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.528600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.889200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.179160E-01 |
| Classical-VS-Follicular |
1.954320E-04 |
| Classical-VS-Other |
1.281370E-01 |
| Classical-VS-Normal |
5.96159999999291E-05 |
| Tall-VS-Follicular |
4.161600E-01 |
| Tall-VS-Other |
4.460800E-01 |
| Tall-VS-Normal |
2.043700E-04 |
| Follicular-VS-Other |
7.832400E-01 |
| Follicular-VS-Normal |
1.18230000234476E-08 |
| Other-VS-Normal |
7.742000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52020000032671E-07 |
| Normal-vs-N1 |
1.93810000004291E-06 |
| N0-vs-N1 |
4.020600E-01 |
|
|
